IGF-1 levels were found to be unaltered in ADHD adults with delayed sleep phase syndrome (DSPS) who were treated for 3 weeks either with just melatonin or melatonin plus 30 min of bright light therapy (BLT) in comparison to a group receiving placebo. Here, IGF1 is linked to attention deficit-hyperactivity disorder.